Why Is Soligenix (SNGX) Stock Up 285% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Soligenix stock is rising higher on Thursday with heavy trading of SNGX shares after getting FDA approval for a Phase 2 clinical trial.

The post Why Is Soligenix (SNGX) Stock Up 285% Today? appeared first on InvestorPlace.

• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors